{"entity":{"type":"insider","cik":"0001361896","url":"/insider/0001361896","json_url":"/insider/0001361896.json","name":"Yorke Justin W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2021-04-15","last":"2025-01-31","span_basis":"filed_date"},"name_variants":[{"name":"Yorke Justin W","source":"filing","n_filings":5,"first_seen":"2021-04-15","last_seen":"2025-01-31"}],"transactions":[{"id":4192091,"accession":"0000897069-25-000153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-25-000153","line_url":"/filing/0000897069-25-000153#line-1","is_derivative":false,"issuer_cik":"0001361896","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001361896","owner_cik":"0001361896","owner_name":"Yorke Justin W","owner_display_name":"Yorke Justin W","owner_url":"/insider/0001361896","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12400.0,"shares_display":"12,400","price_per_share":0.7975,"price_display":"0.80","price_state":"stated","total_value":9889.0,"total_display":"9,889.00","total_whole":"9,889","shares_owned_after":12400.0,"shares_owned_after_display":"12,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-27","filed_date":"2025-01-31","scope":"insider"},{"id":3245592,"accession":"0000897069-24-000227","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-24-000227","line_url":"/filing/0000897069-24-000227#line-1","is_derivative":false,"issuer_cik":"0001361896","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001361896","owner_cik":"0001361896","owner_name":"Yorke Justin W","owner_display_name":"Yorke Justin W","owner_url":"/insider/0001361896","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":2.693,"price_display":"2.69","price_state":"stated","total_value":21544.0,"total_display":"21,544.00","total_whole":"21,544","shares_owned_after":31232.0,"shares_owned_after_display":"31,232","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-30","filed_date":"2024-01-31","scope":"insider"},{"id":6459206,"accession":"0001567619-22-002079","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-002079","line_url":"/filing/0001567619-22-002079#line-1","is_derivative":false,"issuer_cik":"0001361896","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001361896","owner_cik":"0001361896","owner_name":"Yorke Justin W","owner_display_name":"Yorke Justin W","owner_url":"/insider/0001361896","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1854.0,"shares_display":"1,854","price_per_share":3.3,"price_display":"3.30","price_state":"stated","total_value":6118.2,"total_display":"6,118.20","total_whole":"6,118","shares_owned_after":532563.0,"shares_owned_after_display":"532,563","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-27","filed_date":"2022-01-31","scope":"insider"},{"id":4907435,"accession":"0001567619-21-021710","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-021710","line_url":"/filing/0001567619-21-021710#line-2","is_derivative":false,"issuer_cik":"0001361896","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001361896","owner_cik":"0001361896","owner_name":"Yorke Justin W","owner_display_name":"Yorke Justin W","owner_url":"/insider/0001361896","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4200.0,"shares_display":"4,200","price_per_share":4.7104,"price_display":"4.71","price_state":"stated","total_value":19783.68,"total_display":"19,783.68","total_whole":"19,784","shares_owned_after":534417.0,"shares_owned_after_display":"534,417","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-07","scope":"insider"},{"id":4907432,"accession":"0001567619-21-021710","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-021710","line_url":"/filing/0001567619-21-021710#line-1","is_derivative":false,"issuer_cik":"0001361896","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001361896","owner_cik":"0001361896","owner_name":"Yorke Justin W","owner_display_name":"Yorke Justin W","owner_url":"/insider/0001361896","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":4.8362,"price_display":"4.84","price_state":"stated","total_value":26599.1,"total_display":"26,599.10","total_whole":"26,599","shares_owned_after":538617.0,"shares_owned_after_display":"538,617","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-03","filed_date":"2021-12-07","scope":"insider"},{"id":4818954,"accession":"0001567619-21-008151","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-008151","line_url":"/filing/0001567619-21-008151#line-2","is_derivative":false,"issuer_cik":"0001361896","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001361896","owner_cik":"0001361896","owner_name":"Yorke Justin W","owner_display_name":"Yorke Justin W","owner_url":"/insider/0001361896","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9700.0,"shares_display":"9,700","price_per_share":9.42,"price_display":"9.42","price_state":"stated","total_value":91374.0,"total_display":"91,374.00","total_whole":"91,374","shares_owned_after":248272.0,"shares_owned_after_display":"248,272","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-14","filed_date":"2021-04-15","scope":"insider"},{"id":4818950,"accession":"0001567619-21-008151","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-008151","line_url":"/filing/0001567619-21-008151#line-1","is_derivative":false,"issuer_cik":"0001361896","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001361896","owner_cik":"0001361896","owner_name":"Yorke Justin W","owner_display_name":"Yorke Justin W","owner_url":"/insider/0001361896","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":9.86,"price_display":"9.86","price_state":"stated","total_value":64090.0,"total_display":"64,090.00","total_whole":"64,090","shares_owned_after":257972.0,"shares_owned_after_display":"257,972","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-13","filed_date":"2021-04-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001533743","name":"Processa Pharmaceuticals, Inc.","url":"/issuer/0001533743","role":"Director","n_filings":5,"first_seen":"2021-04-15","last_seen":"2025-01-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001361896","retrieved_at":"2026-08-25T05:29:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}